FDA
approval
· 2024-07-18
FDA Approved: ZITUVIMET XR — Original Application (Zydus Pharmaceuticals USA Inc.)
Summary
FDA approved ZITUVIMET XR (sitagliptin and metformin hydrochloride) as an extended-release fixed-dose combination for adults with type 2 diabetes mellitus to im…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ZITUVIMET XR (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE)